FDA
approval
· 2026-04-06
FDA Approved: DAPAGLIFLOZIN — Original Application (Ajanta Pharma USA Inc.)
Summary
FDA approved the original application for dapagliflozin generic from Ajanta Pharma USA Inc., making the SGLT2 inhibitor available as a generic treatment for typ…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DAPAGLIFLOZIN (DAPAGLIFLOZIN)